Core Lab Reports Third Quarter 2026 Results:

Core Labs posts stable Q3 results with modest growth and cautious near-term outlook.

What the company is saying

Core Laboratories Inc. reports third quarter 2026 revenue of $132.1 million, a 6% sequential increase but a 2% year-over-year decline. Operating income was $12.1 million (GAAP) and $12.6 million (ex-items), with ex-items operating margins at 10% and sequential incremental margins of 43%. EPS was $0.12 (GAAP) and $0.16 (ex-items), with the company highlighting a 46% sequential rise in ex-items EPS but a 27% year-over-year drop. CEO Larry Bruno emphasizes sequential revenue growth across both operating segments and improved international demand, especially in the Middle East late in the quarter. The company points to ongoing geopolitical instability in the Middle East and Russia-Ukraine as headwinds but notes project wins in the Middle East and Australia, and expanding technology adoption in North and South America. Core Lab stresses its asset-light model, disciplined capital allocation, and a focus on return on invested capital, reporting a Q3 ROIC of 5.9%. The company frames its Q4 2026 guidance as flat to modestly higher, citing continued disruptions and seasonal effects.

What the data suggests

Q3 2026 revenue was $132,100,000, up 6% sequentially but down 2% year-over-year. Operating income was $12,100,000 (GAAP) and $12,600,000 (ex-items), with ex-items margins at 10%. Free cash flow was $1,700,000, calculated from $5,000,000 in cash from operations and $3,300,000 in capital expenditures. The company repurchased 87,873 shares for $1,100,000 and reduced net debt by $200,000 to $93,400,000, with a leverage ratio under 1.50. Reservoir Description revenue was $84,300,000 (up 7% sequentially, down 4% YoY), with operating income of $7,700,000 (GAAP) and $8,100,000 (ex-items). Production Enhancement revenue was $47,800,000 (up 4% sequentially, up 3% YoY), with operating income of $4,300,000 (GAAP) and $4,400,000 (ex-items); product sales rose 14% sequentially. Dividend payments were $0.01 per share for Q3 and Q4. Q4 2026 guidance projects revenue of $128,500,000 to $134,500,000, operating income of $10,700,000 to $15,100,000, and EPS of $0.12 to $0.20. The data shows modest sequential growth, stable margins, and cautious near-term projections, with ongoing geopolitical and supply chain risks impacting operations.

Analysis

The announcement is a standard quarterly financial and operational update, with the majority of claims supported by realised, audited figures for Q3 2026. The company discloses revenue, operating income, margins, EPS (GAAP and non-GAAP), free cash flow, segment performance, and capital allocation actions, including dividends and share repurchases. Forward-looking statements are present but mostly limited to Q4 2026 guidance and general commentary on industry trends; these projections are near-term and proportionate to the company's historical disclosure practices. There is no evidence of exaggerated tone or narrative inflation: the language is factual, and the forward-looking ratio is moderate, with most key claims realised. Capital expenditures are modest and tied to operational needs or insurance recovery, not to speculative long-term projects. The absence of prior-period figures for some metrics limits trend verification, but this does not constitute hype or overstatement.

Risk flags

• ●Geopolitical instability in the Middle East and Russia-Ukraine continues to disrupt operations and demand, with the company reporting project delays and ongoing volatility in commodity prices. This risk directly impacts both revenue and the timing of client projects.
• ●Supply chain constraints and increased raw material costs for perforating systems have raised inventory carrying costs and working capital requirements, potentially pressuring margins and cash flow if disruptions persist.
• ●The company’s Q4 outlook is flat to modestly higher, with management citing continued disruptions and seasonal slowdowns, indicating limited near-term growth visibility and heightened sensitivity to external shocks.
• ●A fire at the Aberdeen facility in 2024 required ongoing capital expenditures for recovery, though insurance covers losses; any further operational incidents could strain resources or delay service delivery.
• ●The company’s leverage ratio remains below 1.50, but net debt is still $93,400,000, which could limit financial flexibility if market conditions worsen or if cash flow weakens further.

Bottom line

Core Laboratories delivered stable Q3 2026 results, with sequential revenue and earnings growth but year-over-year declines in key metrics. The company is managing through geopolitical and supply chain headwinds, maintaining modest free cash flow and reducing net debt slightly. Segment performance was mixed, with international demand supporting Reservoir Description and strong U.S. product sales driving Production Enhancement. Guidance for Q4 2026 is cautious, projecting flat to slightly higher revenue and earnings, reflecting ongoing disruptions and seasonal effects. While the company highlights technology wins and a disciplined capital approach, near-term growth is constrained by external risks. Investors should focus on the company's ability to sustain margins, manage working capital, and navigate geopolitical volatility as the primary determinants of future performance.

Announcement summary

(NYSE:CLB) Core Laboratories Inc. reported third quarter 2026 revenue of $132,100,000. Operating income for the quarter was $12,100,000, with GAAP earnings per diluted share of $0.12. Operating income, ex-items, was $12,600,000, yielding operating margins of 10% and sequential incremental margins of 43%. EPS, ex-items, was $0.16. Free cash flow for the quarter was $1,700,000, calculated as cash from operations of $5,000,000 less capital expenditures of $3,300,000. The company repurchased 87,873 shares of common stock at an aggregate purchase price of approximately $1,100,000. As of September 30, 2026, net debt was $93,400,000, a reduction of $200,000 from the prior period. The company’s leverage ratio was under 1.50. Reservoir Description segment revenue for Q3 2026 was $84,300,000, up 7% sequentially and down 4% year-over-year, with GAAP operating income of $7,700,000 and ex-items operating income of $8,100,000. Production Enhancement segment revenue was $47,800,000, up 4% sequentially and 3% year-over-year, with GAAP operating income of $4,300,000 and ex-items operating income of $4,400,000. Product sales in Production Enhancement rose 14% sequentially. During the quarter, Core Lab was awarded an expanded analytical program by a leading national oil company in the Middle East and engaged by Omega Oil and Gas to evaluate core samples from two appraisal wells in Queensland, Australia. The company also supported a North American oilfield service company with its AERO™ platform and a Brazilian operator with SpectraFlood™ technology for waterflood optimization. Capital expenditures related to insurance recovery for a fire at the Aberdeen, Scotland facility were approximately $500,000 in Q3 2026. The Board declared a quarterly cash dividend of $0.01 per share, paid August 31, 2026, and approved another $0.01 per share dividend payable November 30, 2026. Core Lab’s return on invested capital for Q3 2026 was 5.9%. The company noted ongoing geopolitical instability in the Middle East and Russia-Ukraine affecting operations and demand. For Q4 2026, Core Lab projects revenue of $128,500,000 to $134,500,000 and operating income of $10,700,000 to $15,100,000, with EPS expected to be $0.12 to $0.20. Reservoir Description Q4 revenue is projected at $81,000,000 to $85,000,000, and Production Enhancement at $47,500,000 to $49,500,000. The company scheduled its Q3 2026 earnings call for October 29, 2026.

Disagree with this article?